An 8-Week, Parallel Group, Double-Blind, Randomized, Placebo & Active-Controlled, Multicenter Study to Evaluate the Efficacy, Safety & Tolerabilty of 2 Formulations of GI181771X, Each at 2 Different Doses, in Obese Subjects

  • Anderson, James (PI)
  • EHTISHAM, AS'AD (CoI)
  • Reynolds, L (CoI)

Grants and Contracts Details

StatusFinished
Effective start/end date5/20/025/31/03